Piper Sandler Maintains Overweight on AbbVie, Raises Price Target to $303
آبفي
AbbVie, Inc. ABBV | 0.00 |
Piper Sandler analyst David Amsellem maintains AbbVie (NYSE:
ABBV) with a Overweight and raises the price target from $298 to $303.
Piper Sandler Maintains Overweight on AbbVie, Raises Price Target to $303
AbbVie, Inc. ABBV | 0.00 |